Solventum (SOLV) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $87.86, +0.69% vs the prior close of $87.26.
- Volume 1.15M shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SOLV rises 0.7% to $87.86, 3 up days in a row. Closed at $87.86, +0.69% vs the prior close of $87.26. Day range $87.25–$89.45, opened at $88.81.
SOLV daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — SOLV rises 0.7% to $87.86, 3 up days in a row
- Closed at $87.86, +0.69% vs the prior close of $87.26. Day range $87.25–$89.45, opened at $88.81.
- Volume was 1.15M shares, 1.1x its 50-day average of 1.01M.
- Price is -0.6% vs its 50-day average ($88.37) and +12.3% vs its 200-day average ($78.23).
- 52-week range $62.38–$94.16; today's close sits at 80% of that range, 6.7% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — SOLV rises 1.1% to $87.26
- Closed at $87.26, +1.11% vs the prior close of $86.30. Day range $85.94–$87.45, opened at $86.49.
- Volume was 1.03M shares, 1.0x its 50-day average of 1.02M.
- Price is -1.3% vs its 50-day average ($88.37) and +11.6% vs its 200-day average ($78.19).
- 52-week range $62.38–$94.16; today's close sits at 78% of that range, 7.3% below the 52-week high.
Oct 13, 2026 — SOLV rises 1.2% to $86.30
- Closed at $86.30, +1.16% vs the prior close of $85.31. Day range $83.29–$86.49, opened at $86.01.
- Volume was 985.00K shares, 1.0x its 50-day average of 1.03M.
- Price is -2.4% vs its 50-day average ($88.38) and +10.4% vs its 200-day average ($78.16).
- 52-week range $62.38–$94.16; today's close sits at 75% of that range, 8.3% below the 52-week high.
Oct 12, 2026 — SOLV dips 2.3% to $85.31, a 1-month low
- Closed at $85.31, -2.27% vs the prior close of $87.29. Day range $84.42–$88.26, opened at $87.00.
- Volume was 1.45M shares, 1.4x its 50-day average of 1.02M.
- Price is -3.5% vs its 50-day average ($88.42) and +9.2% vs its 200-day average ($78.12).
- 52-week range $62.38–$94.16; today's close sits at 72% of that range, 9.4% below the 52-week high.
Oct 9, 2026 — SOLV rises 1.0% to $87.29
- Closed at $87.29, +1.02% vs the prior close of $86.41. Day range $86.66–$88.23, opened at $86.66.
- Volume was 1.06M shares, 1.0x its 50-day average of 1.03M.
- Price is -1.3% vs its 50-day average ($88.42) and +11.8% vs its 200-day average ($78.10).
- 52-week range $62.38–$94.16; today's close sits at 78% of that range, 7.3% below the 52-week high.
Oct 8, 2026 — SOLV rises 0.6% to $86.41
- Closed at $86.41, +0.62% vs the prior close of $85.88. Day range $85.25–$86.79, opened at $85.80.
- Volume was 1.29M shares, 1.2x its 50-day average of 1.04M.
- Price is -2.3% vs its 50-day average ($88.41) and +10.7% vs its 200-day average ($78.07).
- 52-week range $62.38–$94.16; today's close sits at 76% of that range, 8.2% below the 52-week high.
Oct 7, 2026 — SOLV dips 1.3% to $85.88, a 1-month low
- Closed at $85.88, -1.33% vs the prior close of $87.04. Day range $85.30–$87.25, opened at $85.62.
- Volume was 981.10K shares, 0.9x its 50-day average of 1.06M.
- Price is -2.9% vs its 50-day average ($88.45) and +10.0% vs its 200-day average ($78.04).
- 52-week range $62.38–$94.16; today's close sits at 74% of that range, 8.8% below the 52-week high.
Oct 6, 2026 — SOLV dips 1.1% to $87.04, a 1-month low
- Closed at $87.04, -1.12% vs the prior close of $88.03. Day range $86.89–$88.93, opened at $88.45.
- Volume was 914.20K shares, 0.9x its 50-day average of 1.07M.
- Price is -1.6% vs its 50-day average ($88.46) and +11.6% vs its 200-day average ($78.02).
- 52-week range $62.38–$94.16; today's close sits at 78% of that range, 7.6% below the 52-week high.
Oct 5, 2026 — SOLV ends flat (+0.2%) to $88.03
- Closed at $88.03, +0.20% vs the prior close of $87.85. Day range $86.74–$88.39, opened at $87.52.
- Volume was 1.04M shares, 1.0x its 50-day average of 1.06M.
- Price is -0.3% vs its 50-day average ($88.33) and +12.9% vs its 200-day average ($77.98).
- 52-week range $62.38–$94.16; today's close sits at 81% of that range, 6.5% below the 52-week high.
Oct 2, 2026 — SOLV ends flat (+0.1%) to $87.85
- Closed at $87.85, +0.09% vs the prior close of $87.77. Day range $87.79–$89.03, opened at $88.21.
- Volume was 880.40K shares, 0.8x its 50-day average of 1.05M.
- Price is -0.3% vs its 50-day average ($88.13) and +12.7% vs its 200-day average ($77.95).
- 52-week range $62.38–$94.16; today's close sits at 80% of that range, 6.7% below the 52-week high.
SOLV latest news & SEC filings
Every SEC filing by or about SOLV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $2.21B (prior year $2.16B) (+2.2% vs Jun 30, 2025)
- Net income: $92.00M (prior year $90.00M) (+2.2% vs Jun 30, 2025)
- Diluted EPS: $0.53 (prior year $0.51) (+3.9% vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade SOLV
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 26, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.75% (largest 2.3%). That is a relatively calm stock.
- Liquidity: about 973.17K shares (≈$85.50M) trade per day on average.
- 52-week position: $87.86 vs a range of $62.38–$94.16 (80% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 0 sales; latest: Amy Mcbride Wendell bought 1,475 shares on Mar 10, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Aug 5, 2026.
- Share count: 170.22M shares outstanding (Jul 31, 2026), -1.8% vs a year earlier.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
SOLV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 88.81 | 89.45 | 87.25 | 87.86 | 1.15M |
| Oct 14, 2026 | 86.49 | 87.45 | 85.94 | 87.26 | 1.03M |
| Oct 13, 2026 | 86.01 | 86.49 | 83.29 | 86.30 | 985.00K |
| Oct 12, 2026 | 87.00 | 88.26 | 84.42 | 85.31 | 1.45M |
| Oct 9, 2026 | 86.66 | 88.23 | 86.66 | 87.29 | 1.06M |
| Oct 8, 2026 | 85.80 | 86.79 | 85.25 | 86.41 | 1.29M |
| Oct 7, 2026 | 85.62 | 87.25 | 85.30 | 85.88 | 981.10K |
| Oct 6, 2026 | 88.45 | 88.93 | 86.89 | 87.04 | 914.20K |
| Oct 5, 2026 | 87.52 | 88.39 | 86.74 | 88.03 | 1.04M |
| Oct 2, 2026 | 88.21 | 89.03 | 87.79 | 87.85 | 880.40K |
| Oct 1, 2026 | 87.82 | 88.55 | 86.26 | 87.77 | 784.50K |
| Sep 30, 2026 | 89.40 | 89.42 | 88.13 | 88.15 | 689.70K |
| Sep 29, 2026 | 89.17 | 89.89 | 88.29 | 89.32 | 848.80K |
| Sep 28, 2026 | 89.01 | 89.89 | 88.36 | 89.54 | 649.10K |
| Sep 25, 2026 | 88.53 | 89.68 | 88.16 | 89.50 | 578.90K |
| Sep 24, 2026 | 88.54 | 89.04 | 88.12 | 88.59 | 635.80K |
| Sep 23, 2026 | 88.18 | 89.52 | 87.74 | 88.37 | 860.10K |
| Sep 22, 2026 | 89.17 | 89.40 | 88.48 | 88.75 | 651.20K |
| Sep 21, 2026 | 88.87 | 89.61 | 88.40 | 88.84 | 660.30K |
| Sep 18, 2026 | 87.61 | 89.53 | 86.53 | 88.84 | 2.32M |
About Solventum
Solventum (SOLV) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in EAGAN, MN. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1964738.
SOLV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carlos Alban | Director | May 18, 2026 |
| Carrie Smith Cox | Director | May 18, 2026 |
| Susan D. Devore | Director | May 18, 2026 |
| Glenn A Eisenberg | Director | May 18, 2026 |
| Shirley Ann Edwards | Director | May 18, 2026 |
| Bryan C Hanson | Chief Executive Officer | Sep 3, 2026 |
| Bernard A Jr Harris | Director | May 18, 2026 |
| Karen J May | Director | May 18, 2026 |
| Elizabeth Mily | Director | May 18, 2026 |
| John H Weiland | Director | May 18, 2026 |
| Amy Mcbride Wendell | Director | May 18, 2026 |
| Darryl L. Wilson | Director | May 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Tammy L Gomez | Chief Human Resources Officer | May 15, 2026 |
| Bryan C Hanson | Chief Executive Officer | Sep 3, 2026 |
| Paul S Harrington | Chief Supply Chain Officer | May 15, 2026 |
| Marcela A. Kirberger | Chief Legal Affairs Officer | May 15, 2026 |
| Heather Knight | Chief Commercial Officer | Mar 9, 2026 |
| Amy Landucci | Chief Information Officer | May 15, 2026 |
| Wayde D. Mcmillan | Chief Financial Officer | May 15, 2026 |
| Mary T Wilcox | Chief Accounting Officer | May 15, 2026 |
| Neil Craig Zieselman | SVP, Controller & CAO | Aug 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 10, 2026 | Amy Mcbride Wendell | Buy | 1,475 | $68.03 |
SOLV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $8.32B | $1.56B | 8.88 | $369.00M |
| Dec 31, 2024 | $8.25B | $479.00M | 2.76 | $1.19B |
| Dec 31, 2023 | $8.20B | $1.35B | 7.79 | $1.92B |
| Dec 31, 2022 | $8.13B | $1.34B | 7.78 | $1.68B |
Latest balance sheet: total assets $14.24B, total liabilities $9.44B, cash $403.00M (as of Jun 30, 2026).
SOLV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $87.47 |
| May 5, 2026 | 8-K Item 2.02 (results) | $69.04 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $76.94 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $66.28 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $71.95 |
| May 8, 2025 | 8-K Item 2.02 (results) | $66.63 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $83.44 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $75.07 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on SOLV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.